CD4 and head and neck squamous cell carcinoma: We have previously reported a significant and sometimes striking enrichment in CD4+CD25+ T cells among tumour-infiltrating lymphocytes in patients with SCCHN (Albers et al, 2004), and thus we hypothesise that these cells may preferentially localise to tumour sites.